Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
Clinical trial NCT01668654 · TERMINATED
Trial details
- NCT number
- NCT01668654
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-04
- Primary completion
- 2013-06-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.